Advertisement
Canada markets open in 56 minutes
  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CAD/USD

    0.7311
    -0.0010 (-0.14%)
     
  • CRUDE OIL

    78.20
    -0.28 (-0.36%)
     
  • Bitcoin CAD

    87,024.09
    -430.49 (-0.49%)
     
  • CMC Crypto 200

    1,319.40
    -45.72 (-3.35%)
     
  • GOLD FUTURES

    2,320.90
    -10.30 (-0.44%)
     
  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     
  • 10-Yr Bond

    4.4890
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,167.00
    -28.50 (-0.16%)
     
  • VOLATILITY

    13.52
    +0.03 (+0.22%)
     
  • FTSE

    8,302.17
    +88.68 (+1.08%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6782
    -0.0010 (-0.15%)
     

GoviEx grants stock options

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Mar 17, 2017) - GoviEx Uranium Inc. (TSX VENTURE:GXU) ("GoviEx" or "Company") announced that, pursuant to its Stock Option Plan, it has granted incentive stock options to certain directors, officers, employees and a consultant to purchase up to an aggregate of 5,980,000 common shares in the capital stock of the Company.

The options are exercisable at a price of $0.32 per share and will vest 25% on the date of grant and thereafter, 25% on each anniversary of the date of grant until fully vested. The options expire on March 17, 2022.

About GoviEx Uranium

GoviEx is a mineral resource company focused on the exploration and development of uranium properties. GoviEx's principal objective is to become a significant uranium producer through the continued exploration and development of its Mine Permitted Madaouela Project and its other uranium properties in Africa.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.